Mammalian Target of Rapamycin , 0 Comments

Over the past decade, interest has increased in the use of exogenous stem cells to optimize lung fix and serve as carriers of a therapeutic gene for genetic airway disease such as cystic fibrosis. analyzed in trachea-lungs and bronchoalveolar lavages using nonfluorescent, sensitive and quantitative methods. ELISA quantitative outcomes demonstrated that 0.4 to 5.5% control

Read More